BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19459819)

  • 1. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.
    Weigt SS; Elashoff RM; Huang C; Ardehali A; Gregson AL; Kubak B; Fishbein MC; Saggar R; Keane MP; Saggar R; Lynch JP; Zisman DA; Ross DJ; Belperio JA
    Am J Transplant; 2009 Aug; 9(8):1903-11. PubMed ID: 19459819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.
    Weigt SS; Copeland CAF; Derhovanessian A; Shino MY; Davis WA; Snyder LD; Gregson AL; Saggar R; Lynch JP; Ross DJ; Ardehali A; Elashoff RM; Palmer SM; Belperio JA
    Am J Transplant; 2013 Apr; 13(4):919-927. PubMed ID: 23398785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome.
    Garantziotis S; Palmer SM
    Am J Transplant; 2009 Aug; 9(8):1705-6. PubMed ID: 19538485
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study.
    Law N; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Younus M; Aram J; Chaparro C; Singer LG; Husain S
    J Heart Lung Transplant; 2019 Sep; 38(9):963-971. PubMed ID: 31300191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.
    Botha P; Archer L; Anderson RL; Lordan J; Dark JH; Corris PA; Gould K; Fisher AJ
    Transplantation; 2008 Mar; 85(5):771-4. PubMed ID: 18337673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.
    Willner DL; Hugenholtz P; Yerkovich ST; Tan ME; Daly JN; Lachner N; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2013 Mar; 187(6):640-7. PubMed ID: 23328523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
    Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.
    Luong ML; Chaparro C; Stephenson A; Rotstein C; Singer LG; Waters V; Azad S; Keshavjee S; Tullis E; Husain S
    Transplantation; 2014 Feb; 97(3):351-7. PubMed ID: 24305637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
    Vital D; Hofer M; Benden C; Holzmann D; Boehler A
    Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.
    Gregson AL; Wang X; Weigt SS; Palchevskiy V; Lynch JP; Ross DJ; Kubak BM; Saggar R; Fishbein MC; Ardehali A; Li G; Elashoff R; Belperio JA
    Am J Respir Crit Care Med; 2013 Mar; 187(5):518-26. PubMed ID: 23328531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
    Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
    Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.